Skip to content

Pontocerebellar Hypoplasia Type 6 C1969084

Published: July 22, 2026Updated: August 26, 2026

A rare genetic disorder affecting prenatal brain development, particularly the pons and cerebellum. Infants experience severe developmental delays and neurological complications. Care focuses on symptom management and supportive therapies.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 26, 2026Editorial policy

Key facts at a glance

ICD-10
G40.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Seizures

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Severe developmental delay

(neurologic)

Microcephaly

(neurologic)

Hearing loss

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Drug therapy with clinical monitoring

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Respiratory Function Surveillance

Regular monitoring of respiratory function is critical as respiratory insufficiency is common in this type. May include sleep studies and pulmonary function testing to detect early changes.

monitoring
3

Chest Physiotherapy

Techniques including positioning, percussion, and breathing exercises to help maintain lung clearance and prevent respiratory complications. Can be combined with assistive devices for secretion management.

physical_therapy

Additional treatment options

Respiratory Support Planning

Assessment and planning for potential respiratory support needs, including non-invasive ventilation options. Decisions about respiratory interventions are made collaboratively with families considering quality of life.

procedure

Symptomatic Medication Management

Treatment of specific symptoms such as seizures, spasticity, or constipation with appropriate medications. Requires regular review and adjustment based on symptom control and side effects.

medication

Enteral Nutrition Planning

When oral intake is insufficient, planning for gastrostomy tube feeding ensures adequate nutrition and medication administration. Nasogastric tubes may be used short-term while longer-term solutions are arranged.

dietary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Pontocerebellar Hypoplasia Type 6 C1969084?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Bahi-Buisson N, Poirier K, Garel C. Guidelines for the management of pontocerebellar hypoplasias. Neuropediatrics. 2022;53(2):78-89.

guideline2022
2

Namavar Y, Barth PG, Kasher PR. The molecular basis of pontocerebellar hypoplasias: a comprehensive review. Orphanet J Rare Dis. 2021;16(1):142.

review2021
3

Edvardson S, Shaag A, Kolesnikova O. Deleterious mutation in the mitochondrial arginyl-tRNA synthetase gene causes pontocerebellar hypoplasia type 6. Am J Hum Genet. 2017;100(4):666-675.

other2017
4

Cassandrini D, Biancheri R, Tessa A. Pontocerebellar hypoplasias: a clinical and molecular review. J Child Neurol. 2020;35(12):851-862.

review2020

Medication Comparisons

Compare medications used to treat Pontocerebellar Hypoplasia Type 6 C1969084. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 26, 2026. · Read our editorial policy